Mark N. Wegman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 6,500 shares at $58.66 ($374K) on 2018-09-11, disclosed to the SEC on 2018-09-11.
Open-market sale of $374k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.31 | 5,500 | $315K | 84.3% |
| 2 | $58.66 | 1,000 | $59K | 15.7% |
| Total | $57.52 avg | 6,500 | $374K | 100% |
| Filing → |
| BSTC | SELL | 2019-05-22 | $768K | — | Filing → |
| BSTC | SELL | 2018-08-23 | $895K | — | Filing → |